Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 12, Issue 8, Pages 1033-1043
Publisher
Informa UK Limited
Online
2012-10-03
DOI
10.1586/era.12.83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients
- (2012) Nirmala Bhoo-Pathy et al. EUROPEAN JOURNAL OF CANCER
- Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier in Early-Stage Estrogen Receptor-Positive Breast Cancer
- (2012) C. M. Kelly et al. ONCOLOGIST
- Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
- (2012) Fabien Reyal et al. PLoS One
- Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
- (2011) S. Aebi et al. ANNALS OF ONCOLOGY
- Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
- (2011) P. Karlsson et al. ANNALS OF ONCOLOGY
- Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
- (2011) J. Albanell et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
- (2011) André Albergaria et al. BMC CANCER
- Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control
- (2011) Jeffrey M. Albert et al. BREAST CANCER RESEARCH AND TREATMENT
- Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?
- (2011) K. H. Allison et al. BREAST CANCER RESEARCH AND TREATMENT
- St. Gallen 2011: Summary of the Consensus Discussion
- (2011) Michael Gnant et al. Breast Care
- A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer
- (2011) H. L. McArthur et al. CLINICAL CANCER RESEARCH
- A population-based validation of the prognostic model PREDICT for early breast cancer
- (2011) G.C. Wishart et al. EJSO
- The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
- (2011) Emiel Rutgers et al. EUROPEAN JOURNAL OF CANCER
- Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14
- (2011) Kathleen I. Pritchard et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer
- (2011) R. Charles Coombes et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial
- (2011) Wolfgang Eiermann et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial
- (2011) Davide Bedognetti et al. JNCI-Journal of the National Cancer Institute
- Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer
- (2011) Peter S. Hall et al. JNCI-Journal of the National Cancer Institute
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proliferation (Ki-67 and Phosphohistone H3) and Oncotype DX Recurrence Score in Estrogen Receptor-positive Breast Cancer
- (2011) Daron J. Williams et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
- (2010) Sara Margolin et al. ACTA ONCOLOGICA
- Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer
- (2010) Robert J. Paridaens et al. BREAST CANCER RESEARCH AND TREATMENT
- Population-based Estimate of the Prevalence of HER-2 Positive Breast Cancer Tumors for Early Stage Patients in the US
- (2010) Kathleen A. Cronin et al. CANCER INVESTIGATION
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
- (2010) Shmuel H. Klang et al. VALUE IN HEALTH
- Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice
- (2009) J. M. Bueno-de-Mesquita et al. ANNALS OF ONCOLOGY
- An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom
- (2009) H E Campbell et al. BRITISH JOURNAL OF CANCER
- 5194 UK national survey on the use of Adjuvantonline as a decision-making tool in early breast cancer (www.adjuvantonline.com)
- (2009) V. Agarwal et al. EJC SUPPLEMENTS
- History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
- (2009) R. J. Santen et al. ENDOCRINE REVIEWS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- The influence of a Gene expression profile on breast cancer decisions
- (2009) Leonard R. Henry et al. JOURNAL OF SURGICAL ONCOLOGY
- Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study
- (2009) Stella Mook et al. LANCET ONCOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
- (2008) Juhi Asad et al. AMERICAN JOURNAL OF SURGERY
- Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations
- (2008) C. Hery et al. ANNALS OF ONCOLOGY
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
- Sensitivity to Input Variability of the Adjuvant! Online Breast Cancer Prognostic Model
- (2008) Elissa M. Ozanne et al. JOURNAL OF CLINICAL ONCOLOGY
- Histopathologic variables predict Oncotype DX™ Recurrence Score
- (2008) Melina B Flanagan et al. MODERN PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started